Correlation Between Lion Biotechnologies and DBS Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lion Biotechnologies and DBS Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lion Biotechnologies and DBS Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lion Biotechnologies and DBS Group Holdings, you can compare the effects of market volatilities on Lion Biotechnologies and DBS Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lion Biotechnologies with a short position of DBS Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lion Biotechnologies and DBS Group.

Diversification Opportunities for Lion Biotechnologies and DBS Group

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lion and DBS is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Lion Biotechnologies and DBS Group Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DBS Group Holdings and Lion Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lion Biotechnologies are associated (or correlated) with DBS Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DBS Group Holdings has no effect on the direction of Lion Biotechnologies i.e., Lion Biotechnologies and DBS Group go up and down completely randomly.

Pair Corralation between Lion Biotechnologies and DBS Group

Assuming the 90 days trading horizon Lion Biotechnologies is expected to generate 3.64 times more return on investment than DBS Group. However, Lion Biotechnologies is 3.64 times more volatile than DBS Group Holdings. It trades about 0.05 of its potential returns per unit of risk. DBS Group Holdings is currently generating about 0.14 per unit of risk. If you would invest  735.00  in Lion Biotechnologies on September 3, 2024 and sell it today you would earn a total of  165.00  from holding Lion Biotechnologies or generate 22.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Lion Biotechnologies  vs.  DBS Group Holdings

 Performance 
       Timeline  
Lion Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lion Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
DBS Group Holdings 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in DBS Group Holdings are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, DBS Group reported solid returns over the last few months and may actually be approaching a breakup point.

Lion Biotechnologies and DBS Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lion Biotechnologies and DBS Group

The main advantage of trading using opposite Lion Biotechnologies and DBS Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lion Biotechnologies position performs unexpectedly, DBS Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DBS Group will offset losses from the drop in DBS Group's long position.
The idea behind Lion Biotechnologies and DBS Group Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments